What is the maximum size of a kidney stone that can pass spontaneously?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Maximum Size of Kidney Stone That Can Pass Spontaneously

Stones ≤5 mm have a 75% chance of spontaneous passage, while stones >5 mm drop to 62% passage rates, with the likelihood decreasing progressively as size increases beyond this threshold. 1

Size-Based Passage Rates

The evidence clearly demonstrates that stone size is the primary determinant of spontaneous passage:

Stones ≤5 mm

  • Overall passage rate: 75% 1
  • Distal ureteral location: 89% passage rate 1
  • Upper ureteral location: 75% passage rate 1
  • Median time to passage: 8 days (range 6-29 days) 1

Stones >5 mm but ≤10 mm

  • Overall passage rate: 62% 1
  • The 2026 AUA guidelines specifically address stones ≤10 mm as candidates for medical expulsive therapy, indicating this is the upper limit where conservative management remains reasonable 2

Size-Specific Breakdown from Research

More granular data shows progressive decline in passage rates 3:

  • ≤1 mm: 87% passage
  • 2-4 mm: 76% passage
  • 5-7 mm: 60% passage
  • 7-9 mm: 48% passage
  • >9 mm: 25% passage

A 2017 study provides even more precise cutoffs 4:

  • 3 mm: 98% passage
  • 4 mm: 81% passage
  • 5 mm: 65% passage
  • 6 mm: 33% passage
  • ≥6.5 mm: 9% passage

Location Matters Significantly

Stone location dramatically affects passage probability 1:

  • Distal ureter: 68-83% passage
  • Mid ureter: 58-70% passage
  • Upper ureter: 49-52% passage

Clinical Decision Points

Conservative Management Appropriate

For stones ≤5 mm in the distal ureter, conservative management with medical expulsive therapy (alpha-blockers) is strongly recommended 2. These patients should be given approximately 30 days for spontaneous passage.

Gray Zone (5-10 mm)

Stones in this range have substantially lower passage rates. For distal ureteral stones ≤10 mm, MET with alpha-blockers remains an option 2, but patients should be counseled that passage rates drop significantly above 5 mm, and surgical intervention may ultimately be needed.

Surgical Intervention Indicated

Stones >10 mm have very low spontaneous passage rates and should not be managed conservatively. The guidelines do not recommend MET for stones >10 mm 2.

Important Caveats

Time frame matters: Even small stones may take up to 31-40 days to pass 5. The 2025 EAU guidelines note typical passage occurs within 17 days (range 6-29) 1.

Additional predictive factors beyond size include 6, 7:

  • Stone density (Hounsfield units >957 predicts failure)
  • Ureteral wall thickness >1.7 mm (increases failure risk 337-fold)
  • Presence of high-grade hydronephrosis (grade ≥2)
  • Elevated inflammatory markers (NLR >2.15, PLR >10.28)

Intervention thresholds: If complications arise (infection, refractory pain, declining renal function), immediate intervention is required regardless of stone size 1. After 2-4 weeks without passage, surgical options should be strongly considered 8.

The practical answer: 5 mm is the realistic cutoff where spontaneous passage remains likely (75%), while stones approaching 10 mm have marginal passage rates and should prompt early discussion of surgical intervention.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.